Cannabis and Glaucoma
- by Prestoncannabisclub
- 4 minutes
In-Depth Look at Glaucoma
The main trigger for glaucoma is the elevated intraocular pressure (IOP) that adversely affects the optic nerve, potentially leading to permanent visual loss. The most common type encountered is primary open-angle glaucoma. Prompt detection and proactive management are essential, as the condition may not show symptoms until significant harm has occurred. Conventional management strategies aim to lower IOP using drugs or surgical interventions, which vary in effectiveness and can have unique side effects.
Cannabis Overview
Cannabis comprises various compounds, notably THC (tetrahydrocannabinol) and CBD (cannabidiol), which interact with the endocannabinoid system in the body. This system regulates functions like pain, mood, and appetite. Cannabis’s medicinal applications include treatments for chronic pain, epilepsy, and as an antiemetic in chemotherapy.
Glaucoma and Cannabis
Potential Benefits Studies from the 1970s suggested that cannabis could lower intraocular pressure, potentially aiding glaucoma patients. The focus was primarily on THC, which interacts with cannabinoid receptors in the eye to reduce pressure. However, the enthusiasm dwindled when it became apparent that cannabis’ effects were short-lived, about three to four hours, necessitating frequent dosing to sustain eye pressure reduction, which could lead to psychoactive impacts and other side effects.
Over time, research has deepened, targeting specific cannabinoids that might be effective without causing psychoactive effects. For instance, CBD is being researched for its possible therapeutic effects on glaucoma without psychoactive outcomes.
Glaucoma: Cannabis and Its Benefits in Treating Disease
The use of cannabis for glaucoma treatment hinges on developing new formulations that offer extended reduction of intraocular pressure with minimal side effects. While cannabis may serve as a supplementary therapy providing temporary relief from high eye pressure when traditional medications fail, its practicality as a primary treatment is limited due to the short duration of its effects and the psychoactive nature of THC.
Risks and Concerns
Potential risks include lower blood pressure and psychological effects. The question of “does cannabis help glaucoma” remains partly unresolved due to the transient nature of its benefits, requiring frequent administration to effectively maintain lower IOP levels.
As research progresses, the future role of cannabis in treating glaucoma will likely depend on new pharmaceutical developments that can sustainably lower intraocular pressure without adverse effects. Patients considering cannabis for glaucoma treatment should evaluate the benefits and risks and consult healthcare professionals to make informed choices.

